DOI QR코드

DOI QR Code

Effects of Hwanggimacmundong-tang on Body Weight and Gene Expression in Obese Rats with Estrogen Deficiency

황기맥문동탕이 에스트로겐 결핍 Rat의 체중 변화와 비만 관련 유전자 발현에 미치는 영향

  • Lee, Hye-In (Dept. of Korean Medicine Obstetrics & Gynecology, College of Korean Medicine, Dae-Jeon University) ;
  • Yoo, Dong-Youl (Dept. of Korean Medicine Obstetrics & Gynecology, College of Korean Medicine, Dae-Jeon University) ;
  • Yoo, Jeong-Eun (Dept. of Korean Medicine Obstetrics & Gynecology, College of Korean Medicine, Dae-Jeon University)
  • 이혜인 (대전대학교 한의과대학 부인과교실) ;
  • 유동열 (대전대학교 한의과대학 부인과교실) ;
  • 유정은 (대전대학교 한의과대학 부인과교실)
  • Received : 2018.04.27
  • Accepted : 2018.03.16
  • Published : 2018.05.25

Abstract

Objectives: This study was conducted to assess the effects of Hwanggimacmundong-tang extract (HM) on obese rats with estrogen deficiency. Methods: The experiments were performed with ovariectomized rats as estrogen-deficient obesity model. Rats were grouped NC (Normal Control Group; sham operation group), OC (Obesity Control Group; estrogen-deficient group), HML (20 mg/kg/day), HMH (100 mg/kg/day). HM was administered orally for six weeks. Body weights and serum lipid level were measured, and real-time PCR was performed to estimate the effect of HM on gene expression in liver. Results: HM decreased the total cholesterol and triglyceride in serum. And HM increased leptin, CPT1 gene expression in liver tissue of obese rats with estrogen deficiency. However HM decreased $PPAR{\gamma}$, $PGC-1{\alpha}$, HMGCR, CYP8B1, LPL, ACAT1, ACAT2, ApoB, ACOX gene expression in liver tissue of obese rats with estrogen deficiency. Conclusions: It is concluded that HM reduced total cholesterol and triglyceride in serum, and regulate gene expression related to lipid metabolism. These results indicate Hwanggimacmundong-tang that might have potential for treatment of obesity and complications during the menopause caused by estrogen-deficiency.

Keywords

References

  1. Korean academy of oriental rehabilitation medicine. Oriental rehabilitation medicine. 3rd ed. Seoul:KoonJa publisher. 2012 :350-4.
  2. World Health Organization(2017). 10 facts on obesity. Fact sheets. 2017. Avaliable from:URL:http://www.who.int/features/factfiles/obesity/en.
  3. The Society of Korean Obstetrics and Gynecology. Korean Obstetrics & Gynecology(Ha) 1st edition. Seoul: Euiseongdang. 2012:295-302.
  4. Cooke PS, Naaz A. Role of Estrogens in Adipocyte Development and Function. Experimental biology and medicine. 2004;229(11):1127-35. https://doi.org/10.1177/153537020422901107
  5. Kim HJ. Effect of Aromatherapy Program on Lowering BMI and Serum Estrogen Level in Obese Post-menopause Women. Korean J Women Health Nurs. 2008; 14(2):150-5.
  6. Kim JM, et al. The Effect of Oral Administration at Herbal Medicines in Animal Models on Obesity: A Review of Animal Study Reports Published in Korea after 2010. Journal of Korean Medicine Rehabilitation. 2017;27(3):13-32. https://doi.org/10.18325/JKMR.2017.27.3.13
  7. Shin HJ, et al. Effects of Pueraria lobata on Body Weight and Gene Expression in Obese Rats Muscle with Estrogen Deficiency. J Korean Obstet Gynecol. 2012;25(3):71-84. https://doi.org/10.15204/JKOBGY.2012.25.3.071
  8. Shin YS, Hwang GS. The effects of Pueraria lobata extract on gene expression in liver tissue of rat with estrogen-deficient obesity. Journal of Society of Preventive Korean Medicine. 2015;18(3):117-28.
  9. Jung SG. Effects of SunGinseng in Gene Expression of 3T3L1 adipocytes and in the Estrogen-deficient Obesity. Doctor's thesis. Graduate School of Kyungwon University. 2007.
  10. Im KR, et al. Analysis of Isoflavonoid Contents in Astragalus membranaceus Bunge Cultivated in Different Areas and at Various Ages. KSBB Journal. 2010;25:271-6.
  11. Zhang XH, Liu SX, Xu M. The research of phytoestrogen and chinese herb. Tradit Chin Drug Res Clin Pharmacol. 2002;13(4):261-4.
  12. Song HS, Suo CZ. The research progress of phytoestrogen and its effect on central nervous system. Liaoning J Tradit Chin Med. 2006;33(10):1372-3.
  13. Lee JM, Lee E, Choi MY. Effects of powdered siho(Bupleuri Radix) on lipid composition and TBARS in rat fed high cholesterol. Kor J Herbology. 2000;15(1):67-71.
  14. Calpe-Berdiel L, Escola-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis. 2009;203:18-31. https://doi.org/10.1016/j.atherosclerosis.2008.06.026
  15. Shin JH, et al. Selection and Mechanism of Anti-Obesity Agents from Natural Products Based on Anti-Angiogenesis. KSBB Journal. 2009;24:122-30.
  16. 2015 Health Behavior and Chronic Disease Statistics. Cheongju:Korea Centers for Disease Control & Prevention. 2016:20-6. Available from: URL:https://knhanes.cdc.go.kr/knhanes/sub04/sub04_03.do?classType=7.
  17. Pasquali R, et al. Body weight, fat distribution and the menopausal status in women. Int J Obes Related Metab Disord. 1994;18:614-21.
  18. Sowers MF, et al. Changes in body composition in women in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92:895-901. https://doi.org/10.1210/jc.2006-1393
  19. Lindheim SR, et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig. 1994;1:150-4. https://doi.org/10.1177/107155769400100210
  20. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88: 2404-11. https://doi.org/10.1210/jc.2003-030242
  21. Gohlke-Bärwolf C. Coronary artery disease is menopause a risk factor? Basic Res Cardiol. 2000;95(1):I77-83. https://doi.org/10.1007/s003950070014
  22. Kim TW, Kang SB. Antiobese and Antidiabetic Effects of Yookmijihwang -tang-gamibang, a Traditional Polyherbal Formula on the Obese and Type II Diabetic C57BL/6JHam-ob/ob Mice. Herbal Formula Science. 2013;21(2) :110-20. https://doi.org/10.14374/HFS.2013.21.2.110
  23. Song SY, et al. Anti-Glycemic and Anti-Lipid Effects of Ethanol Extract of Supungsunkih-wan-gagambang in High Fat Diet-induced Obese Mice. J Korean Oriental Med. 2011;32(5) :1-11.
  24. Lee HI, et al. Effects of Gami-Handayeolso -Tang on Body Fat Reduction in High Fat Diet-Fed Obese Mice. Journal of Korean Medicine Rehabilitation. 2016;26(1):13-31. https://doi.org/10.18325/JKMR.2016.26.1.13
  25. Yoon YS, et al. Effects of Cheongshimyeonja -tang on the Body Weight and Serum Lipid Levels in High Fat Diet Induced Obese Mice. Herbal Formula Science. 2014;22(1):123-39. https://doi.org/10.14374/HFS.2014.22.1.123
  26. Lee MJ, et al. Effects of Choweseungcheng -tang on Obesity and Hyperlipidemia in High-fat-diet-induced Obese Mice. J Korean Oriental Med. 2011;32(4): 37-47.
  27. Oh SW, Kim BW. Effects of Jowiseungcheung -tang Extract on the Lipid Metabolism, Anti-oxidation and Inflammatory Reflex High Fat Diet Obese Rats. Korean J Orient Int Med. 2013;34(1):1-13.
  28. Hwang JP, Yoon IJ. The Anti-obesity Effects of Gambibang 4 on Obesity-induced Mice. J Korean Oriental Med. 2010;31(1):30-46.
  29. Yang DH, et al. The Effects of Taeyeumjowee-tang and Taeyeumjoweebaemahwang-tang on Obese rats. Kor J Herbology. 2010; 25(3):103-9.
  30. Le MD, Jung PE. The Effects of Dai-saiko-to(Da-Chai-Hu-Tang) on 3T3-L1 Preadipocytes and High-Fat Diet-Induced Obese Mice. J Pediatr Korean Med. 2015;29(1):1-14. https://doi.org/10.7778/jpkm.2015.29.1.001
  31. Chun JM, et al. The Anti-obesity Effect of 5 Herbal Formulas in High Fat Diet Induced Obese Mice. Herbal Formula Science. 2013;21(2): 44-52. https://doi.org/10.14374/HFS.2013.21.2.044
  32. National Oriental Medicine School Coeditorship of Herbal Medicines Professors. Herbal Medicine. 2nd rev. ed. Seoul:Youngrimsa. 2008:186-7, 231-2, 576-8, 644-5, 687-88.
  33. Andreasen CH, et al. Studies of CTNNBL1 and FDFT1 variants and measures of obesity: analyses of quantitative traits and case-control studies in 18,014 Danes. BMC Med Genet. 2009;10:17.
  34. Li MD. Leptin and beyond: an odyssey to the central control of body weight. Yale J Biol Med. 2011;84(1):1-7.
  35. Pedersen SBP, et al. Estrogen controls lipolysis by up-regulating alpha2A adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin. Endocrinol Metab. 2004;89:1869-78. https://doi.org/10.1210/jc.2003-031327
  36. Nakagami H, Morishita R. Obesity and gastrointestinal hormones-dual effect of angiotensin II receptor blockade and a partial agonist of PPAR-${\gamma}$. Curr Vasc Pharmacol. 2011; 9(2):162-6. https://doi.org/10.2174/157016111794519291
  37. Lee SB, Keum DH, Lee MJ. Oriental and Western Medical Study on the cause and treatment of Obesity. The Journal of Dong Guk Oriental Medicine. 1996;5(1):33-52.
  38. Matsuzawa Y, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29-33. https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  39. Jo Y, Debose-Boyd RA. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit Rev Biochem Mol Biol. 2010;45(3):185-98. https://doi.org/10.3109/10409238.2010.485605
  40. Lundell K, Wikvall K. Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. Curr Drug Metab. 2008;9(4):323-31. https://doi.org/10.2174/138920008784220574
  41. Meir K, et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J Biol Chem. 2002;277(37) :3436-41.
  42. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89(3):331-40. https://doi.org/10.1016/S0092-8674(00)80213-5
  43. Khor VK, et al. Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice. AmJ Physiol Endocrinol Metab. 2010;299(4):657-64. https://doi.org/10.1152/ajpendo.00707.2009
  44. Yang L, et al. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone. Cell Res. 2004;14(4):315-23. https://doi.org/10.1038/sj.cr.7290231
  45. Contois JH, et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2009;55(3): 407-19. https://doi.org/10.1373/clinchem.2008.118356
  46. Hood DA, et al. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol. 2006;209(12):2265-75. https://doi.org/10.1242/jeb.02182
  47. Poirier Y, et al. Peroxisomal beta- oxidation-a metabolic pathway with multiple functions. Biochim Biophys Acta. 2006;1763(12):1413-26. https://doi.org/10.1016/j.bbamcr.2006.08.034
  48. Navarra T, et al. The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb. 2010;17(4):317-31. https://doi.org/10.5551/jat.3228

Cited by

  1. 에스트로겐이 결핍된 흰쥐에서 한약혼합물이 비만 관련 호르몬에 미치는 영향 vol.30, pp.1, 2018, https://doi.org/10.18325/jkmr.2020.30.1.1